Sickle-cell disease and malaria: Evaluation of seasonal intermittent preventive treatment with sulfadoxine-pyrimethamine in Senegalese patients - A randomized placebo-controlled trial

Annals of Hematology

Volumn 90, Issue 1, 2011, Pages 23-27

  Diop, Saliou ^a   Soudré, Fabienne ^a   Seck, Moussa ^a   Guèye, Youssou Bamar ^a   Diéye, Tandakha Ndiaye ^a   Fall, Awa Oumar Touré ^a   Sall, Abibatou ^a   Thiam, Doudou ^a   Diakhaté, Lamine ^a  

^a UNIVERSITÉ CHEIKH ANTA DIOP   (Senegal)

Author keywords

Anemia; Malaria; Sickle cell disease; Sulfadoxine pyrimethamine

Indexed keywords

ARTEMISININ; ASPARTATE AMINOTRANSFERASE; FOLIC ACID; PARACETAMOL; PLACEBO; PYRIMETHAMINE; PYRIMETHAMINE PLUS SULFADOXINE; QUININE; SULFADOXINE;

ADULT; ANTIBIOTIC PROPHYLAXIS; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BLOOD CELL COUNT; BLOOD VESSEL OCCLUSION; BONE PAIN; DISEASE SEVERITY; DISEASE TRANSMISSION; DOUBLE BLIND PROCEDURE; DRUG INTERMITTENT THERAPY; DRUG SAFETY; DRUG TOLERABILITY; ERYTHROCYTE CONCENTRATE; FEMALE; FEVER; HOSPITALIZATION; HUMAN; HYPERBILIRUBINEMIA; MAJOR CLINICAL STUDY; MALARIA; MALARIA FALCIPARUM; MALE; MORBIDITY; MORTALITY; PAIN; PATIENT COMPLIANCE; PREVALENCE; PRIORITY JOURNAL; PRURITUS; RANDOMIZED CONTROLLED TRIAL; SEASON; SENEGAL; SHIVERING; SICKLE CELL ANEMIA; SIDE EFFECT; SWEATING; VASOOCCLUSIVE CRISIS; VOMITING;

ADOLESCENT; ADULT; ANEMIA, SICKLE CELL; ANTIMALARIALS; DOUBLE-BLIND METHOD; DRUG COMBINATIONS; FEMALE; HUMANS; INCIDENCE; MALARIA; MALE; PERIODICITY; PLACEBOS; PYRIMETHAMINE; SEASONS; SENEGAL; SULFADOXINE; YOUNG ADULT;

EID: 78651306864     PISSN: 09395555     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00277-010-1040-z     Document Type: Article

References (26)

1. B Modell M Darlison 2008 Global epidemiology of hemoglobin disorders and derived service indicators Bull World Health Organ 86 480 487 10.2471/BLT.06.036673 18568278 (Pubitemid 351821761)
2. M Mbodj O Ndoye M Diarra BN Mbaye H Sow Toure L Diouf, et al. 2003 Sickle cell disease neonatal screening: first evaluation Dak Med 48 202 205 1:STN:280:DC%2BD2M7ksVOmsg%3D%3D
3. World Health Organization (2006) Management of birth defects and hemoglobin disorders: report of a joint WHO-March of Dimes meeting. World Health Organ, Geneva
4. M Adjuik T Smith S Clark J Todd A Garrib Y Kinfu, et al. 2006 Cause-specific mortality rates in sub-Saharan Africa and Bangladesh Bull World Health Organ 84 181 188 10.2471/BLT.05.026492 16583076 (Pubitemid 43352398)
5. J May JA Evans C Timmann C Ehmen W Busch T Thye, et al. 2007 Hemoglobin variants and disease manifestations in severe falciparum malaria JAMA 297 20 2220 2226 1:CAS:528:DC%2BD2sXlvVKitrc%3D 10.1001/jama.297.20.2220 17519411 (Pubitemid 47010879)
6. S Diop G Koffi E N'Dahtz O Allangba MA Aka Adjo I Sanogo, et al. 1997 Infection in sickle cell disease Bull Soc Path Ex 90 339 341 1:STN:280:DyaK1c7mvVKisg%3D%3D
7. GR Serjeant 2005 Mortality from sickle cell disease in Africa BMJ 330 432 433 10.1136/bmj.330.7489.432 15731125
8. S Diop M Ndiaye M Seck B Chevalier R Jambou A Sarr, et al. 2009 Prevention of transfusion transmitted malaria in endemic area Tranfus Clin Biol 16 454 459 1:STN:280:DC%2BD1Mfgt1OnsQ%3D%3D 10.1016/j.tracli.2009.02.004
9. GW Fegan AM Noor WS Akhwale S Cousens RW Snow 2007 Effect of expanded insecticide-treated bed net coverage on child survival in rural Kenya: a longitudinal study Lancet 370 9592 1035 1039 10.1016/S0140-6736(07)61477-9 17889242 (Pubitemid 47419019)
10. F Manzi G Hutton J Schellenberg M Tanner P Alonso H Mshinda D Schellenberg 2008 From strategy development to routine implementation: the cost of intermittent preventive treatment in infants for malaria control BMC Health Serv Res 31 1 19
11. Committee on the Perspectives on the Role of Intermittent Preventive Treatment for Malaria in infants (2008) Assessment of the role on intermittent preventive treatment for malaria in infants: letter report. National Academies Press, Washington, DC
12. B Cisse C Sokhna D Boulanger J Milet EH Bâ K Richardson, et al. 2006 Seasonal intermittent preventive treatment with artesunate and sulfadoxine-pyrimethamine for prevention of malaria in Senegalese children: a randomized, placebo-controlled, double-blind trial Lancet 367 659 667 1:CAS:528:DC%2BD28Xhslylsbk%3D 10.1016/S0140-6736(06)68264-0 16503464 (Pubitemid 43289156)
13. V Briand G Cottrell A Massougbodji M Cot 2007 Intermittent preventive treatment for the prevention of malaria during pregnancy in high transmission areas Malar J 6 1 7 10.1186/1475-2875-6-160
14. S Diop SO Mokono M Ndiaye AO Toure-Fall D Thiam L Diakhaté 2003 Homozygous sickle cell disease in patients above 20 years of age: follow-up of 108 patients in Dakar Rev Med Intern 24 711 715 1:STN:280:DC%2BD3srislOkuw%3D%3D 10.1016/S0248-8663(03)00220-0 (Pubitemid 37409082)
15. V Machault L Gadiaga C Vignolles F Jarjaval S Bouzid C Sokhna, et al. 2009 Highly focused anopheline breeding sites and malaria transmission in Dakar Malar J 8 1 21 10.1186/1475-2875-8-138
16. G Pasvol 2009 Are children with homozygous sickle cell disease really at a disadvantage in the face of malaria? The malaria hypothesis revisited Clin Infect Dis 49 223 224 10.1086/599835 19514857
17. J Makani AN Komba SE Kox J Oruo K Mwamtemi J Kitundu, et al. 2010 Malaria in patients with sickle cell anemia: burden, risk factors, and outcome at the outpatient clinic and during hospitalization Blood 115 215 220 1:CAS:528:DC%2BC3cXhtlKls7s%3D 10.1182/blood-2009-07-233528 19901265
18. D Diallo G Tchernia 2002 Sickle cell disease in Africa Curr Opin Hematol 9 111 116 10.1097/00062752-200203000-00005 11844993 (Pubitemid 34171486)
19. O Oniyangi AA Omari 2006 Malaria chemoprophylaxis in sickle cell disease Cochrane Database Syst Rev 4 CD003489 17054173
20. YM Tatfeng DE Agbonlahor KS Tchounga PI Omolu M Okodua CS Yah, et al. 2008 Chloroquine prophylaxis associated with high prevalence of Plasmodium falciparum pfcrt K76T mutation in people with sickle-cell disease in Benin City, Nigeria J Vector Borne Dis 45 1 51 55 1:STN:280:DC%2BD1c3ktVejuw%3D%3D 18399317
21. MA Warley DJS Hamilton PD Marsden RE Brown JG Merselis N Wilks 1965 Chemoprophylaxis of homozygous sicklers with antimalarials and long acting penicillin BMJ 5453 86 88 10.1136/bmj.2.5453.86
22. V Nakibuuka G Ndeezi D Nakiboneka CM Ndugwa JK Tumwine 2009 Presumptive treatment with sulfadoxine-pyrimethamine versus weekly chloroquine for malaria prophylaxis in children with sickle cell anemia in Uganda: a randomized controlled trial Malar J 8 223 228 10.1186/1475-2875-8-237
23. FU Eke I Anochie 2003 Effects of pyrimethamine versus proguanil in malaria chemoprophylaxis in children with sickle cell disease, a randomized placebo controlled open label study Curr Ther Res 64 C16 C25 10.1016/j.curtheres.2003.09.003 (Pubitemid 37449516)
24. WM Watkins EK Mberu PA Winstanley CV Plowe 1997 The efficacy of antimalarial combinations in Africa: a predictive model based on pharmacodynamic and pharmacokinetic analyses Parasitol Today 13 459 464 1:CAS:528: DyaK2sXnvFGhu7o%3D 10.1016/S0169-4758(97)01124-1 15275132
25. CJ Sutherland CJ Drakeley D Schellenberg 2007 How is childhood development of immunity to Plasmodium falciparum enhanced by certain antimalarial interventions Malar J 6 161 10.1186/1475-2875-6-161 18053225
26. Gaye O, Tine RC, Ndiaye JL (2009) Enquête Nationale sur le Paludisme 2008-2009 (ENPS-II). Ministry of Health, Republic of Senegal